{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T02:47:40Z","timestamp":1782442060793,"version":"3.54.5"},"reference-count":24,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T00:00:00Z","timestamp":1706918400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000770","name":"University of Manchester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000770","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","epilepsybehavior.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.yebeh.2024.109680","type":"journal-article","created":{"date-parts":[[2024,2,8]],"date-time":"2024-02-08T23:04:33Z","timestamp":1707433473000},"page":"109680","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["The lived experience of young adults with Fetal Valproate Spectrum Disorder, and the perspective of their parents: A qualitative study"],"prefix":"10.1016","volume":"152","author":[{"given":"S","family":"Khanom","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Astill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Astill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Cozens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Garratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R L","family":"Bromley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2024.109680_b0005","doi-asserted-by":"crossref","unstructured":"Bromley R, et al. Monotherapy treatment of epilepsy in pregnancy: congenital malformation outcomes in the child. Cochrane Database Syst Rev 2023;8. Art. No. CD010224.","DOI":"10.1002\/14651858.CD010224.pub3"},{"key":"10.1016\/j.yebeh.2024.109680_b0010","doi-asserted-by":"crossref","unstructured":"Bromley R, et al. Treatment for epilepsy in pregnancy: neurodevelopmental outcomes in the child. Cochrane Database Syst Rev 2014;10. Art. No. CD010236.","DOI":"10.1002\/14651858.CD010236.pub2"},{"issue":"7","key":"10.1016\/j.yebeh.2024.109680_b0015","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1001\/jamaneurol.2022.1269","article-title":"Association of Prenatal Exposure to Antiseizure Medication With Risk of Autism and Intellectual Disability","volume":"79","author":"Bj\u00f8rk","year":"2022","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2024.109680_b0020","doi-asserted-by":"crossref","unstructured":"Clayton-Smith J, et al. Diagnosis and management of individuals with Fetal Valproate Spectrum Disorder; a consensus statement from the European Reference Network for Congenital Malformations and Intellectual Disability. Orphanet J Rare Dis 2019;14(1):180:1\u201321.","DOI":"10.1186\/s13023-019-1064-y"},{"key":"10.1016\/j.yebeh.2024.109680_b0025","doi-asserted-by":"crossref","unstructured":"Bluett-Duncan M, et al. Neurodevelopmental outcomes in children and adults with Fetal Valproate Spectrum Disorder: A contribution from the ConcePTION project. Neurotoxicol Teratol 2023;100:107292. 1\u201310.","DOI":"10.1016\/j.ntt.2023.107292"},{"key":"10.1016\/j.yebeh.2024.109680_b0030","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.ntt.2018.11.003","article-title":"Intellectual functioning in clinically confirmed fetal valproate syndrome","volume":"71","author":"Bromley","year":"2019","journal-title":"Neurotoxicol Teratol"},{"issue":"6","key":"10.1016\/j.yebeh.2024.109680_b0035","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S1474-4422(18)30107-8","article-title":"Comparative risk of major congenital malformations with eight different antiepileptic drugs: a prospective cohort study of the EURAP registry","volume":"17","author":"Tomson","year":"2018","journal-title":"Lancet Neurol"},{"issue":"11","key":"10.1016\/j.yebeh.2024.109680_b0040","doi-asserted-by":"crossref","first-page":"902","DOI":"10.1136\/archdischild-2013-303945","article-title":"New understanding of adolescent brain development: relevance to transitional healthcare for young people with long term conditions","volume":"98","author":"Colver","year":"2013","journal-title":"Arch Dis Child"},{"issue":"2","key":"10.1016\/j.yebeh.2024.109680_b0045","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1467-8721.2007.00475.x","article-title":"Risk Taking in Adolescence: New Perspectives From Brain and Behavioral Science","volume":"16","author":"Steinberg","year":"2007","journal-title":"Curr Dir Psychol Sci"},{"key":"10.1016\/j.yebeh.2024.109680_b0050","unstructured":"Armstrong, K., et al., Social Functioning in Young People with Fetal Valproate Spectrum Disorder. Unpublished results, 2023."},{"issue":"2","key":"10.1016\/j.yebeh.2024.109680_b0055","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1191\/1478088706qp063oa","article-title":"Using thematic analysis in psychology","volume":"3","author":"Braun","year":"2006","journal-title":"Qual Res Psychol"},{"issue":"4","key":"10.1016\/j.yebeh.2024.109680_b0060","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1089\/aut.2020.0083","article-title":"\u201cMasking Is Life\u201d: Experiences of Masking in Autistic and Nonautistic Adults","volume":"3","author":"Miller","year":"2021","journal-title":"Autism Adulthood"},{"issue":"6","key":"10.1016\/j.yebeh.2024.109680_b0065","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1001\/jamaneurol.2023.0674","article-title":"Prenatal Exposure to Antiseizure Medication and Incidence of Childhood- and Adolescence-Onset Psychiatric Disorders","volume":"80","author":"Dreier","year":"2023","journal-title":"JAMA Neurol"},{"key":"10.1016\/j.yebeh.2024.109680_b0070","doi-asserted-by":"crossref","first-page":"1","DOI":"10.5324\/nje.v24i1-2.1806","article-title":"Using the Norwegian Mother and Child Cohort Study to determine risk factors for delayed development and neuropsychiatric","volume":"24","author":"Bj\u00f8rk","year":"2014","journal-title":"Norsk Epidemiologi"},{"issue":"3","key":"10.1016\/j.yebeh.2024.109680_b0075","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1212\/WNL.0000000000000030","article-title":"In utero exposure to levetiracetam vs valproate: development and language at 3 years of age","volume":"82","author":"Shallcross","year":"2014","journal-title":"Neurology"},{"issue":"1","key":"10.1016\/j.yebeh.2024.109680_b0080","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.yebeh.2008.10.011","article-title":"The behavioral consequences of exposure to antiepileptic drugs in utero","volume":"14","author":"Vinten","year":"2009","journal-title":"Epilepsy Behav"},{"issue":"2","key":"10.1016\/j.yebeh.2024.109680_b0085","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.yebeh.2011.06.014","article-title":"Fetal antiepileptic drug exposure: motor, adaptive, and emotional\/behavioral functioning at age 3 years","volume":"22","author":"Cohen","year":"2011","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2024.109680_b0090","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ntt.2016.01.001","article-title":"Behavioral outcomes in children exposed prenatally to lamotrigine, valproate, or carbamazepine","volume":"54","author":"Deshmukh","year":"2016","journal-title":"Neurotoxicol Teratol"},{"issue":"7","key":"10.1016\/j.yebeh.2024.109680_b0095","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1177\/1362361319830029","article-title":"\u2018I definitely feel more in control of my life\u2019: The perspectives of young autistic people and their parents on emerging adulthood","volume":"23","author":"Cribb","year":"2019","journal-title":"Autism"},{"issue":"3","key":"10.1016\/j.yebeh.2024.109680_b0100","doi-asserted-by":"crossref","first-page":"e0264932","DOI":"10.1371\/journal.pone.0264932","article-title":"\u201cWe couldn't think in the box if we tried. We can't even find the damn box\u201d: A qualitative study of the lived experiences of autistic adults and relatives of autistic adults","volume":"17","author":"Finch","year":"2022","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.yebeh.2024.109680_b0105","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/bdr2.1967","article-title":"Transgenerational adverse effects of valproate? A patient report from 90 affected families","volume":"114","author":"Martin","year":"2022","journal-title":"Birth Defects Res"},{"key":"10.1016\/j.yebeh.2024.109680_b0110","series-title":"The Report of the Independent Medicines and Medical Devices Safety Review","author":"Cumberlege","year":"2023"},{"key":"10.1016\/j.yebeh.2024.109680_b0115","unstructured":"European Medicines Agency. PRAC recommends new measures to avoid topiramate exposure in pregnancy. 2023; Available from: https:\/\/www.ema.europa.eu\/en\/news\/prac-recommends-new-measures-avoid-topiramate-exposure-pregnancy#:\u223c:text=For%20patients%20using%20topiramate%20for,no%20other%20suitable%20treatment%20available."},{"issue":"7","key":"10.1016\/j.yebeh.2024.109680_b0125","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1136\/jmg.37.7.489","article-title":"A clinical study of 57 children with fetal anticonvulsant syndromes","volume":"37","author":"Moore","year":"2000","journal-title":"J Med Genet"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024000611?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505024000611?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T18:53:32Z","timestamp":1761504812000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505024000611"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":24,"alternative-id":["S1525505024000611"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.109680","relation":{},"ISSN":["1525-5050"],"issn-type":[{"value":"1525-5050","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The lived experience of young adults with Fetal Valproate Spectrum Disorder, and the perspective of their parents: A qualitative study","name":"articletitle","label":"Article Title"},{"value":"Epilepsy & Behavior","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.yebeh.2024.109680","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"109680"}}